Pioneer of the chemically functionalized glucides
NeTech Inc.


[Animal studies]
Topical drug delivery system

  • KytoGel including drugs forms adhesive hydrogel and stays at the affected part through UV irradiation.
  • KytoGel decomposes at the affected part, and then releases the included substances.




Inclusion of growth factors
KytoGEL including fibroblast growth factor (FGF) enables to accelerate refractory wound healing of the diabetic mice.

  • Refractory trauma of diabetic mice was treated with KytoGEL including FGF-2.
  • FGF which was released following biodegradation of KytoGEL accelerates
  • IIIIneovascularization leading to wound healing.
  • Inclusion with KytoGEL enables to suppress the deactivation of growth factors.
  • BBBBBBBBBBBBiomaterials 2004;26:3277-3284.
  • BBBBBBBBBBBWound Rep Reg 2005; 13: 390-397.




Inclusion of chemotherapeutics
KytoGEL including Paclitaxel inhibited the expansion of model tumor which was established at mouse back.

  • KytoGel including Paclitaxel (Pac) was subcutaneously injected into mouse back
  • IIIIestablishing model tumor with B-16 melanoma, and then subjected to
  • IIIIUV irradiation.
  • KytoGel including Pac suppressed angiogenesis of the model tumor.
  • KytoGel including Pac inhibited expansion of tumor.


(Journal of Controlled Release 2005; 110: 390-397)

  • Topically stayed-drug delivery will reduce applied dose of drugs, and then suppress a IIIIrisk of side effect.
  • KytoGel varies a use of drugs and elevates worth of the generics.






LinkIconHemostat
LinkIconEndoscope
LinkIconWound care